Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings

Homozygous Familial Hypercholesterolemia (HoFH) - 7MM Market, Epidemiology, and Forecast - 2036 | RNAi and Targeted Therapies Expand Uptake and Investment Opportunities

The HoFH market is expected to expand through 2036, driven by improved genetic screening, earlier diagnosis, and adoption of targeted lipid-lowering therapies. With approximately 1,840 diagnosed prevalent cases in the 7MM in 2025, the market is shifting toward long-acting, receptor-independent therapies including RNA interference agents and ANGPTL3 inhibitors. Key unmet needs include limited treatment efficacy for patients with minimal LDL receptor function, delayed diagnosis, and high treatment burden.

Goldman Sachs Reinstates Neutral on Arrowhead Pharma, Announces $74 Price Target

Goldman Sachs analyst Andrea Newkirk reinstates Arrowhead Pharma (NASDAQ:ARWR) with a Neutral and announces $74 price target.

Nasdaq 100 Slips, 10-Year Yields Hit 19-Year Highs: Stock Market Today

Stocks slid as the 10-year Treasury yield hit a 19-year high on blowout PMI data; cybersecurity stocks bucked the selloff.

Arrowhead Achieves Clinical Validation for New Drug Platform

Arrowhead Pharmaceuticals reports interim Phase 1/2a data for ARO-DIMER-PA, demonstrating dual-gene silencing to treat high fat in blood.

Why GE Vernova Stock Trounced the Market Today

GE Vernova stock surged nearly 4% after Oppenheimer analyst Colin Rusch named it the top stock pick in the power engineering sector. The analyst cited strong growth driven by AI infrastructure buildout and President Trump's executive order banning Chinese bulk power equipment imports, which gives GE Vernova significant pricing power and competitive advantage.

Shares of data center infrastructure-related companies are trading higher after Google and Constellation energy announced a 20-year partnership to bring 890 MW of nuclear power online, which helps underpin strong demand for future compute buildout. Also, Baird initiating coverage of Modine Manufacturing with an Outperform rating and a $300 price target further supports the sector.